Compare market size and growth of key Healthcare markets

Compare market size and growth of key Healthcare markets

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Loading...

Categories

16 Philippines Active Pharmaceutical Ingredients Reports

Asia Pacific DPP Drugs Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: AstraZeneca, Eli Lilly and Company, Merck and Co., Novartis AG, Bristol-Myers Squibb

Asia-Pacific Alpha-Glucosidase Inhibitors Industry

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Takeda, Pfizer, Bayer, Sun Pharma, Glenmark

Asia Pacific SGLT2 Inhibitors Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Eli Lilly, Boehringer Ingelheim, Janssen Pharmaceuticals, AstraZeneca, Bristol Myers Squibb

APAC Biguanide Industry

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Takeda, Bristol-Myers Squibb, Glenmark, Merck and Co., Sanofi Aventis

Asia-Pacific GLP 1 Agonist Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: AstraZeneca, Eli Lilly and Company, Novo Nordisk A/S, Sanofi Aventis, Biocon Ltd.

APAC Insulin Market

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Eli Lilly, Sanofi, Biocon, Gan & Lee

APAC Meglitinide Industry

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Novo Nordisk, Glenmark, Novartis, Kissei, Biocon

Alpha Glucosidase Inhibitor Drugs Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Sun Pharma, Bayer, Takeda, Torrent Pharmaceuticals, Pfizer Inc.

Meglitinides Market

Country Covered: Philippines

Study Period: 2019- 2029

Major Players: Glenmark Pharmaceuticals, Novartis, Kissei Pharmaceuticals, Biocon, Novo Nordisk A/S

SGLT2 Inhibitors Market

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals, Astellas

DPP4 Drugs Industry

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Merck, AstraZeneca, Boehringer Ingelheim Pharmaceuticals Inc., Pfizer Inc., Eli Lilly and Company

Glargine Insulin Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Sanofi Aventis, Novo Nordisk AS, Biocon, Eli Lilly and Company, Julphar

Basal Insulin (Long-Acting Insulin) Market

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon, Wockhardt

GLP-1 Agonists Market

Country Covered: Philippines

Study Period: 2019- 2029

Major Players: AstraZeneca, Eli Lilly and Company, Sanofi, Novo Nordisk A/S, Pfizer Inc.

Sulfonylureas Industry

Country Covered: Philippines

Study Period: 2019- 2029

Major Players: Sanofi Aventis, Pfizer Inc., Merck & Co., Inc., Torrent Pharma, Dr. Reddy's Laboratories

Biguanides Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Bristol Myers Squibb, Glenmark Pharmaceuticals, Takeda, Sanofi Aventis, Merck and Co.